Each site will invite all eligible patients to participate. Patients will be followed for up to 5 years or until patient withdrawal of consent, loss to follow-up, death, or the end of the study, whichever comes first.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has a diagnosis of ATTR-CM
Is initiating treatment with vutrisiran or another approved ATTR-CM therapy
You may not be if
Is enrolled in an interventional clinical trial
Clareo Health | DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
